Investigating Pericyte Roles in Blood-Brain Barrier Formation

研究周细胞在血脑屏障形成中的作用

基本信息

  • 批准号:
    10390466
  • 负责人:
  • 金额:
    $ 36.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-05-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The blood-brain barrier (BBB) acts as a signaling and transport interface between the blood and brain. The BBB begins to form early in embryonic development as the mesoderm-derived vasculature invades the immature central nervous system (CNS) and acquires BBB characteristics such as tight junctions and a lack of fenestrae. After further maturation, the adult BBB, with its very low permeability and a wealth of molecular transport systems, is maintained by interactions with supporting cells of the neurovascular unit (NVU). Recent studies have indicated the importance of CNS pericytes in BBB formation, with pericytes triggering reduced transcytosis, reduced expression of leukocyte adhesion molecules and proper tight junction organization. However, the identity of pericyte-derived factors that can elicit these important changes during BBB formation are not known. Thus, our understanding of the molecular mechanisms underpinning BBB formation is incomplete; and in this proposal, we aim to further examine the mechanisms by which brain pericytes impact BBB formation. A powerful and innovative approach to explore BBB formation is the use of human induced pluripotent stem cell (iPSC) technology to model the BBB and the associated support cells of the NVU. We will demonstrate that not only can brain pericytes be differentiated from iPSCs, they can also regulate key BBB properties in iPSC-derived brain endothelial cells (BMECs). In parallel, using genomics approaches, we have identified a cohort of pericyte-derived secreted factors, several of which can induce BBB properties in iPSC- derived BMECs. Combining these approaches, we will examine the mechanisms whereby pericyte-derived secreted factors can differentially regulate BBB formation in iPSC-derived BMECs. Preliminary data indicate that one of the pericyte-derived secreted factors, BMP5, can influence hallmark BBB properties known to be regulated by brain pericytes. Namely, BMP5 can reduce transcytosis and improve tight junction structures in iPSC-derived BMECs. To further examine the mechanism by which BMP5 regulates BBB formation during development, we will use genetic mouse models to explore whether BMP5 signaling is necessary for BBB formation and function. Finally, we will assess whether BMP5 supplementation can be therapeutic in a mouse model of multiple sclerosis. Understanding the pericyte-derived regulators of BBB formation could yield many new mechanistic insights regarding brain diseases that have demonstrable pericyte involvement. Knowledge of the barrier formation pathways could also open new avenues for restoring BBB function in debilitating neurological disease.
摘要

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intrinsic blood-brain barrier dysfunction contributes to multiple sclerosis pathogenesis.
内在的血脑屏障功能障碍导致多发性硬化症的发病机制。
  • DOI:
    10.1093/brain/awac019
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nishihara,Hideaki;Perriot,Sylvain;Gastfriend,BenjaminD;Steinfort,Marel;Cibien,Celine;Soldati,Sasha;Matsuo,Kinya;Guimbal,Sarah;Mathias,Amandine;Palecek,SeanP;Shusta,EricV;Pasquier,RenaudDu;Engelhardt,Britta
  • 通讯作者:
    Engelhardt,Britta
Differentiation of human pluripotent stem cells to brain microvascular endothelial cell-like cells suitable to study immune cell interactions.
  • DOI:
    10.1016/j.xpro.2021.100563
  • 发表时间:
    2021-06-18
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nishihara H;Gastfriend BD;Kasap P;Palecek SP;Shusta EV;Engelhardt B
  • 通讯作者:
    Engelhardt B
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC V SHUSTA其他文献

ERIC V SHUSTA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC V SHUSTA', 18)}}的其他基金

New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
  • 批准号:
    10581615
  • 财政年份:
    2021
  • 资助金额:
    $ 36.78万
  • 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
  • 批准号:
    10208481
  • 财政年份:
    2021
  • 资助金额:
    $ 36.78万
  • 项目类别:
New Human Antibodies for CNS Drug Delivery
用于中枢神经系统药物输送的新型人类抗体
  • 批准号:
    10376351
  • 财政年份:
    2021
  • 资助金额:
    $ 36.78万
  • 项目类别:
Investigating Pericyte Roles in Blood-Brain Barrier Formation
研究周细胞在血脑屏障形成中的作用
  • 批准号:
    9975931
  • 财政年份:
    2018
  • 资助金额:
    $ 36.78万
  • 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
  • 批准号:
    10470403
  • 财政年份:
    2018
  • 资助金额:
    $ 36.78万
  • 项目类别:
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease
探索阿尔茨海默病中的血脑屏障功能障碍
  • 批准号:
    10242177
  • 财政年份:
    2018
  • 资助金额:
    $ 36.78万
  • 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
  • 批准号:
    9920222
  • 财政年份:
    2017
  • 资助金额:
    $ 36.78万
  • 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
  • 批准号:
    10186832
  • 财政年份:
    2017
  • 资助金额:
    $ 36.78万
  • 项目类别:
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery
能够无创脑部药物输送的七鳃鳗抗体的鉴定
  • 批准号:
    9380557
  • 财政年份:
    2017
  • 资助金额:
    $ 36.78万
  • 项目类别:
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier
RXRalpha 和 PPARdelta 信号作为血脑屏障的新型调节剂
  • 批准号:
    8660105
  • 财政年份:
    2013
  • 资助金额:
    $ 36.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了